Phase-pure perovskite lead titanate with various morphologies has been synthesized by a hydrothermal method at 150 °C. Particle shapes include cubic, tabular, and aggregated platelike shapes. The feedstock concentration greatly influences particle morphology of the hydrothermally derived PbTiO3. At a concentration of 0.05 M, the tabular particles form while cubic particles are produced at 0.1 M. Aggregated plateletlike particles are synthesized at 0.125 M. It was observed that both tabular and cubic particles directly precipitate from the coprecipitated precursor gel. In contrast, the plateletlike shaped intermediate phase appears during the initial stage of reaction at 0.125 M and in situ transforms into perovskite PbTiO3 during further hydrothermal treatment. The intermediate phase preserves its particle shape during transformation and, acting as a template, gives rise to the final tabular PbTiO3 particles. It is demonstrated that only base reagents such KOH and NaOH, which provide a highly basic condition (i.e., pH > 14), promote transformation of the coprecipitated gel into the perovskite PbTiO3. A Hancock and Sharp kinetic analysis in conjunction with microstructural evidence suggests that the formation mechanism is dissolution and recrystallization in which the degree of supersaturation plays an important role in dictating the crystallographic particle phase and morphology of the particles. An experimentally constructed solubility diagram indicates that an excess lead condition is necessary to compensate for loss of lead species and to increase supersaturation to expedite precipitation of PbTiO3 at highly alkaline conditions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.